A.M. Dräger

1.2k total citations
18 papers, 559 citations indexed

About

A.M. Dräger is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, A.M. Dräger has authored 18 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in A.M. Dräger's work include Acute Myeloid Leukemia Research (3 papers), Platelet Disorders and Treatments (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). A.M. Dräger is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Platelet Disorders and Treatments (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). A.M. Dräger collaborates with scholars based in Netherlands, United States and United Kingdom. A.M. Dräger's co-authors include M. M. A. C. Langenhuijsen, Adri Zevenbergen, C. Ellen van der Schoot, Karin Schweitzer, Paul van der Valk, S. F. T. Thijsen, Peter C. Huijgens, Sonja Zweegman, J W van Oostveen and Andries R. Jonkhoff and has published in prestigious journals such as British Journal of Cancer, International Journal of Radiation Oncology*Biology*Physics and European Journal of Cancer.

In The Last Decade

A.M. Dräger

18 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A.M. Dräger Netherlands	11	213	188	168	160	157	18	559
Philip G. Hargreaves United Kingdom	8	323 1.5×	126 0.7×	86 0.5×	130 0.8×	183 1.2×	12	608
AM Turner United States	8	162 0.8×	198 1.1×	151 0.9×	170 1.1×	45 0.3×	8	551
Francesca Merchionne Italy	13	194 0.9×	362 1.9×	251 1.5×	84 0.5×	77 0.5×	21	670
Jonathan Back Switzerland	15	152 0.7×	345 1.8×	222 1.3×	434 2.7×	122 0.8×	32	1.0k
M.H. Prandini France	9	304 1.4×	447 2.4×	53 0.3×	108 0.7×	130 0.8×	13	801
Lijun Leng United States	6	265 1.2×	181 1.0×	31 0.2×	138 0.9×	292 1.9×	8	550
Patrik Georgii‐Hemming Sweden	14	233 1.1×	409 2.2×	244 1.5×	133 0.8×	38 0.2×	17	778
Kumar B. Reddy United States	13	119 0.6×	448 2.4×	239 1.4×	84 0.5×	251 1.6×	14	807
Ganwei Lu United States	13	86 0.4×	473 2.5×	222 1.3×	270 1.7×	71 0.5×	17	799
Sonja E. Gustin Australia	10	106 0.5×	406 2.2×	169 1.0×	212 1.3×	29 0.2×	13	676

Countries citing papers authored by A.M. Dräger

Since Specialization

Citations

This map shows the geographic impact of A.M. Dräger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Dräger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Dräger more than expected).

Fields of papers citing papers by A.M. Dräger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M. Dräger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Dräger. The network helps show where A.M. Dräger may publish in the future.

Co-authorship network of co-authors of A.M. Dräger

This figure shows the co-authorship network connecting the top 25 collaborators of A.M. Dräger. A scholar is included among the top collaborators of A.M. Dräger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.M. Dräger. A.M. Dräger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Chamuleau, Martine E.D., et al.. (2007). P093 Changes in the flowcytometric dysplasia score during treatment with erythropoietin/G-CSF reflect responses in low/int-I risk myelodysplastic syndromes. Leukemia Research. 31. S90–S90. 1 indexed citations

Netelenbos, Tanja, Sonja Zweegman, J W van Oostveen, et al.. (2003). Proteoglycans on bone marrow endothelial cells bind and present SDF-1 towards hematopoietic progenitor cells. Leukemia. 17(1). 175–184. 74 indexed citations

Thijs, Abel, W.M. van Baal, Marius J. van der Mooren, et al.. (2002). Effects of hormone replacement therapy on blood platelets. European Journal of Clinical Investigation. 32(8). 613–618. 33 indexed citations

Boer, Fransien de, A.M. Dräger, E. van der Wall, et al.. (2000). The phenotypic profile of CD34-positive peripheral blood stem cells in different mobilization regimens. British Journal of Haematology. 111(4). 1138–1144. 13 indexed citations

Boer, Fransien de, A.M. Dräger, E. van der Wall, et al.. (2000). The phenotypic profile of CD34‐positive peripheral blood stem cells in different mobilization regimens. British Journal of Haematology. 111(4). 1138–1144. 2 indexed citations

Thijsen, S. F. T., G.J. Schuurhuis, J W van Oostveen, et al.. (1999). Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitors. British Journal of Cancer. 79(9-10). 1406–1412. 5 indexed citations

Dräger, A.M., GJ Ossenkoppele, Andries R. Jonkhoff, G.J. Schuurhuis, & P.C. Huijgens. (1998). New strategies in hematopoietic stem cell transplantation: G-CSF-mobilized unprocessed whole blood. Brazilian Journal of Medical and Biological Research. 31(1). 49–53. 6 indexed citations

Leeuwen‐Stok, A. Elise van, et al.. (1996). Effect of modulation of the transferrin receptor on gallium-67 uptake and cytotoxicity in lymphoma cell lines. British Journal of Cancer. 74(4). 619–624. 4 indexed citations

Leeuwen‐Stok, A. Elise van, et al.. (1996). Radiotoxic effect and dosimetry of 67Ga in multicellular spheroids as compared to single cells of the lymphoma cell line U715. International Journal of Radiation Oncology*Biology*Physics. 35(3). 507–517. 5 indexed citations

10.

Ossenkoppele, G.J., G.J. Schuurhuis, Andries R. Jonkhoff, et al.. (1996). High-dose melphalan with re-infusion of unprocessed, G-CFS-primed whole blood is effective and non-toxic therapy in multiple myeloma. European Journal of Cancer. 32(12). 2058–2063. 10 indexed citations

11.

Schweitzer, Karin, A.M. Dräger, Paul van der Valk, et al.. (1996). Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues.. PubMed. 148(1). 165–75. 254 indexed citations

12.

Ossenkoppele, G. J., Gerrit‐Jan Schuurhuis, Andries R. Jonkhoff, et al.. (1996). G-CSF (filgrastim)-stimulated whole blood kept unprocessed at 4 degrees C does support a BEAM-like regimen in bad-risk lymphoma.. PubMed. 18(2). 427–31. 19 indexed citations

13.

Schweitzer, Christine, C. Ellen van der Schoot, A.M. Dräger, et al.. (1995). Isolation and culture of human bone marrow endothelial cells.. PubMed. 23(1). 41–8. 56 indexed citations

14.

Hem, K.G. van der, et al.. (1994). The differentiation inducing effect of bryostatin 5 on human myeloid blast cells is potentiated by vitamin D3.. PubMed. 8(2). 266–73. 13 indexed citations

15.

Ossenkoppele, G.J., Andries R. Jonkhoff, P.C. Huijgens, et al.. (1994). Peripheral blood progenitors mobilised by G-CSF (filgrastim) and reinfused as unprocessed autologous whole blood shorten the pancytopenic period following high-dose melphalan in multiple myeloma.. PubMed. 13(1). 37–41. 23 indexed citations

16.

Schweitzer, Christine, Arjan A. van de Loosdrecht, Andries R. Jonkhoff, et al.. (1993). Spectrophotometric determination of clonogenic capacity of leukemic cells in a semisolid microtiter culture system.. PubMed. 21(4). 573–8. 9 indexed citations

17.

Leeuwen‐Stok, A. Elise van, et al.. (1993). Gallium 67 in the Human Lymphoid Cell Line U-715: Uptake, Cytotoxicity and Intracellular Localization. International Journal of Radiation Biology. 64(6). 749–759. 17 indexed citations

18.

Mitas, John A., et al.. (1983). Diabetic neuropathic pain: control by amitriptyline and fluphenazine in renal insufficiency.. PubMed. 76(4). 462–3, 467. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact